WebAug 20, 2010 · Dr Anthony Baxter, Cyprotex’s Chief Executive Officer, comments on the launch of the new toxicology facility. “Drug toxicity, and drug-induced liver injury in … WebAug 20, 2010 · Dr Anthony Baxter, Cyprotex's Chief Executive Officer, comments on the launch of the new toxicology facility. "Drug toxicity, and drug-induced liver injury in particular, is a major reason for...
Phototoxicity Testing Charles River
WebFounded in 1999, Cyprotex (www.cyprotex.com) has grown to become an industry leader in in vitro and in silico ADME-Tox. The company, with sites in the UK and USA, was acquired by Evotec... Web• Cyprotex’s phototoxicity service is a non-GLP screening assay performed using Balb/c 3T3 cells. The cells are incubated with increasing concentrations of the test article in the … smart build post frame
Drug‐induced photosensitivity: culprit drugs, potential …
WebThe dermal phototoxicity of a chemical is defined as a toxic response that is elicited after exposure of skin to the chemical or systemic administration of the chemical, and subsequent exposure to light. As demonstrated in several validation studies (1Œ3), the phototoxic potential of chemicals can be effec-tively assessed by in vitro methods ... WebAug 20, 2010 · Dr Anthony Baxter, Cyprotex’s Chief Executive Officer, comments on the launch of the new toxicology facility. “Drug toxicity, and drug-induced liver injury in particular, is a major reason for failures in clinical trials and for the withdrawal of previously approved drugs from the market. WebThis gives Cyprotex's Macclesfield site the same in vitro toxicology capabilities as those of Apredica (Watertown, MA, USA), which Cyprotex acquired on 6 August 2010. ... hERG inhibition; - toxicological gene regulation; - phospholipidosis; - phototoxicity; - haemolysis; - genotoxicity; and - a full spectrum of drug-drug interaction assays. smart build properties ltd